Deerfield Capital LP
Director, 10% owner at NUVL; 10% owner at QTTB; 10% owner at ACRS, and 11 more
- Sold, on record
- $245M
- Dollars the filings state
- Form 4 sales
- 17
- Latest Oct 22, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 14
- Filed as an executive or holder
Companies
- NUVLNuvalent, Inc.Director, 10% owner
- QTTBQ32 Bio Inc.10% owner
- ACRSAclaris Therapeutics, Inc.10% owner
- Societal CDMO, Inc.10% owner
- Invuity, Inc.10% owner
- AXGNAxogen, Inc.10% owner
- ANTARES PHARMA, INC.10% owner
- CAS MEDICAL SYSTEMS INC10% owner
- SALIX PHARMACEUTICALS LTD10% owner
- NITROMED INC10% owner
- ARENA PHARMACEUTICALS INC10% owner
- INSPIRE PHARMACEUTICALS INC10% owner
- THIRD WAVE TECHNOLOGIES INC /WI10% owner
- PAR PHARMACEUTICAL COMPANIES, INC.10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- NUVL2M shares
- CAS MEDICAL SYSTEMS INC1.4M shares
- ANTARES PHARMA, INC.1.3M shares
- SALIX PHARMACEUTICALS LTD1M shares
- PAR PHARMACEUTICAL COMPANIES, INC.632,047 shares
- NITROMED INC460,831 shares
- INSPIRE PHARMACEUTICALS INC403,330 shares
- AXGN381,439 shares
- THIRD WAVE TECHNOLOGIES INC /WI365,435 shares
- Invuity, Inc.184,796 shares
- QTTB164,730 shares
- Societal CDMO, Inc.62,868 shares
- ARENA PHARMACEUTICALS INC25,000 shares
- ACRS1,704 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ANTARES PHARMA, INC.Plan not statedJul 8, 2015 2015
Sold 834,505 shares at $2.08 ($1.7M)
Deerfield Mgmt L.P., 10% owner
Sold 11.8% of holdings ($14.7M position)6.2M shares leftFiling
- 2 Form 4 sale AXGNPlan not statedJul 18, 2016 +376 days
Sold 279,303 shares at $7.53 ($2.1M)
Deerfield Mgmt L.P., 10% owner
Sold 8.3% of holdings ($25.5M position)3.1M shares leftFirst sale on recordFiling
- 3 Form 4 sale AXGNPlan not statedJul 21, 2016 +3 days
Sold 102,136 shares at $6.70 ($684k)
Deerfield Mgmt L.P., 10% owner
Sold 3.3% of holdings ($20.8M position)3M shares leftFiling
- 4 Form 4 sale Invuity, Inc.Plan not statedDec 14, 2016 +146 days
Sold 184,796 shares at $6.22 ($1.1M)
Deerfield Mgmt L.P., 10% owner
Sold 9.9% of holdings ($11.7M position)1.7M shares leftFirst sale on recordFiling
- 5 Form 4 sale Societal CDMO, Inc.Plan not statedJun 8, 2017 +176 days
Sold 62,868 shares at $7.06 ($444k)
Deerfield Mgmt L.P., 10% owner
Sold 4.7% of holdings ($9.5M position)1.3M shares leftFirst sale on recordFiling
- 6 Form 4 sale ACRSPlan not statedJun 26, 2019 +748 days
Sold 1,704 shares at $4.50 ($8k)
Deerfield Mgmt L.P., 10% owner
Sold 0% of holdings ($16.9M position)3.7M shares leftFirst sale on recordFiling
- 7 Form 4 sale QTTBPlan not statedDec 23, 2019 +180 days
Sold 164,730 shares at $21.78 ($3.6M)
Deerfield Mgmt L.P., 10% owner
Sold 7.9% of holdings ($45.3M position)1.9M shares leftFirst sale on recordFiling
- 8 Form 4 sale NUVLNo planOct 22, 2024 +1765 days
Sold 2M shares at $97.75 ($196M)
Deerfield Mgmt L.P., Director, 10% owner
No 10b5-1 planSold 18.7% of holdings ($1B position)8.7M shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (17)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 22, 2024 | Oct 24, 2024 | NUVL | Director, 10% owner | Form 4 sale | 2M | $196M | 18.7% | No plan | SEC |
| Dec 23, 2019 | Dec 23, 2019 | QTTB | 10% owner | Form 4 sale | 164,730 | $3.6M | 7.9% | Plan not stated | SEC |
| Jun 26, 2019 | Jun 26, 2019 | ACRS | 10% owner | Form 4 sale | 1,704 | $8k | 0.0% | Plan not stated | SEC |
| Jun 8, 2017 | Jun 9, 2017 | Societal CDMO, Inc. | 10% owner | Form 4 sale | 62,868 | $444k | 4.7% | Plan not stated | SEC |
| Dec 14, 2016 | Dec 14, 2016 | Invuity, Inc. | 10% owner | Form 4 sale | 184,796 | $1.1M | 9.9% | Plan not stated | SEC |
| Jul 21, 2016 | Jul 21, 2016 | AXGN | 10% owner | Form 4 sale | 102,136 | $684k | 3.3% | Plan not stated | SEC |
| Jul 18, 2016 | Jul 18, 2016 | AXGN | 10% owner | Form 4 sale | 279,303 | $2.1M | 8.3% | Plan not stated | SEC |
| Jul 8, 2015 | Jul 8, 2015 | ANTARES PHARMA, INC. | 10% owner | Form 4 sale | 834,505 | $1.7M | 11.8% | Plan not stated | SEC |
| Jun 18, 2015 | Jun 18, 2015 | ANTARES PHARMA, INC. | 10% owner | Form 4 sale | 478,366 | $1.2M | 6.1% | Plan not stated | SEC |
| Jan 1, 2015 | Jan 5, 2015 | CAS MEDICAL SYSTEMS INC | 10% owner | Form 4 sale | 1.4M | $2.4M | 100.0% | Unusual | SEC |
| Sep 10, 2009 | Sep 10, 2009 | SALIX PHARMACEUTICALS LTD | 10% owner | Form 4 sale | 1M | $13.4M | 25.9% | Unusual | SEC |
| Dec 23, 2008 | Dec 24, 2008 | NITROMED INC | 10% owner | Form 4 sale | 460,831 | $258k | 12.3% | Plan not stated | SEC |
| Oct 19, 2007 | Oct 23, 2007 | ARENA PHARMACEUTICALS INC | 10% owner | Form 4 sale | 25,000 | $263k | 0.8% | Plan not stated | SEC |
| Apr 30, 2007 | May 2, 2007 | INSPIRE PHARMACEUTICALS INC | 10% owner | Form 4 sale | 403,330 | $3.1M | 14.9% | Plan not stated | SEC |
| Apr 24, 2007 | Apr 24, 2007 | THIRD WAVE TECHNOLOGIES INC /WI | 10% owner | Form 4 sale | 86,685 | $499k | 8.0% | Plan not stated | SEC |
| Apr 19, 2007 | Apr 20, 2007 | THIRD WAVE TECHNOLOGIES INC /WI | 10% owner | Form 4 sale | 278,750 | $1.6M | 20.9% | Plan not stated | SEC |
| Feb 1, 2007 | Feb 1, 2007 | PAR PHARMACEUTICAL COMPANIES, INC. | 10% owner | Form 4 sale | 632,047 | $17M | 22.5% | Plan not stated | SEC |